Clinical course and management of acute hepatitis a infection in adults

Annals of Hepatology

Volumn 11, Issue 5, 2012, Pages 652-657

  Mackinney Novelo, Ileana ^a   Barahona Garrido, Josué ^b   Castillo Albarran, Fátima ^a   Santiago Hernández, Jean J ^a   Méndez Sánchez, Nahum ^a   Uribe, Misael ^a   Chávez Tapia, Norberto ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b Unit of Gastroenterology and Digestive Endoscopy   (Guatemala)

Author keywords

Acute liver failure; Latin america; Mortality; Risk factors

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BILIRUBIN; CREATININE; NITROGEN; S ADENOSYLMETHIONINE; UREA; URSODEOXYCHOLIC ACID; VITAMIN K GROUP; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ACUTE LIVER FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; GUATEMALA; HEPATITIS A; HOSPITAL ADMISSION; HUMAN; JAUNDICE; LEUKOCYTE COUNT; MALAISE; MALE; MEXICO; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL; ACUTE DISEASE; BLOOD; MULTICENTER STUDY; PREDICTIVE VALUE; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; UNNECESSARY PROCEDURE; VIROLOGY;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; GUATEMALA; HEPATITIS A; HUMANS; LIVER FAILURE, ACUTE; MALE; MEXICO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNNECESSARY PROCEDURES; YOUNG ADULT;

EID: 84865314406     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31438-3     Document Type: Article

References (18)

1. Di Giammarino L, Dienstag JL. Hepatitis A-the price of progress. New Engl J Med 2005; 353: 944-946.
2. Panduro A, Escobedo Melendez G, Fierro NA, Ruiz Madrigal B, Zepeda-Carrillo EA, Roman S. Epidemiology of viral hepatitis in Mexico. Sal Pub Mex 2011; 53(Suppl. 1): S37-S45.
3. Garcia-Juarez I, Solorzano Santos F, Alvarez-y-Munoz MT, Vazquez-Rosales JG. Is there a shift in the epidemiology of hepatitis A in Mexican children?. Rev Invest Clin 2008; 60: 292-296.
4. Kumate J, Alvizouri AM, Isibasi A. Serologic survey of hepatitis A antibodies in Mexican children. Bulletin of the Pan American Health Organization 1982; 16: 156-160.
5. Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiology and infection 1994; 113: 113-120.
6. Moon HW, Cho JH, Hur M, Yun YM, Choe WH, Kwon SY, Lee CH. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift. WJG 2010; 16: 1115-1118.
7. Hussain Z, Das BC, Husain SA, Murthy NS, Kar P. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. J Gastroenterology and Hepatology 2006; 21: 689-693.
8. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18(Suppl. 1): S57-S60.
9. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology 2010; 53: 15-19.
10. Souza LJ, Braga LC, Rocha Nde S, Tavares RR. Acute acal-culous cholecystitis in a teenager with hepatitis a virus infection: a case report. Braz J Infect Dis 2009; 13: 74-76.
11. Amariei R, Willms AR, Bauch CT. The United States and Canada as a coupled epidemiological system: an example from hepatitis A. BMC Infect Dis 2008; 8: 23.
12. Barrientos-Gutierrez T, Brizuela-Alcantara D, Chavez-Ta-pia NC. Hepatitis A virus infection in high-risk subjects. Ann Hepatol 2011; 10: 578-579.
13. Vento S. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. J Viral Hepat 2000; 7(Suppl. 1): 7-8.
14. Junaidi O, Di Bisceglie AM. Aging liver and hepatitis. Clinics in geriatric medicine 2007; 23: 889-903, viii.
15. Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int 2009; 29: 392-398.
16. Cho SY, Choi SH, Park JH, Chung JW. Initial laboratory predictors of severe hepatitis and acute kidney injury in patients with acute hepatitis A. Diagn Microbiol Infect Dis 2011; 69: 400-404.
17. Wilkinson SP, Davies MH, Portmann B, Williams R. Renal failure in otherwise uncomplicated acute viral hepatitis. British Medical J 1978; 2: 338-341.
18. Kim SH, Yoon HE, Kim YK, Kim JY, Choi BS, Choi YJ, Kim YO, et al. Acute hepatitis A-associated acute renal failure in adults. Nephron Clinical Practice 2008; 109: c127-c132.